Amundi Asset Management US’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-281
Closed -$10K – 1564
2020
Q3
$10K Hold
281
– – ﹤0.01% 1523
2020
Q2
$11K Hold
281
– – ﹤0.01% 1532
2020
Q1
$10K Sell
281
-6,050
-96% -$235K ﹤0.01% 1528
2019
Q4
$256K Hold
6,331
– – ﹤0.01% 1421
2019
Q3
$220K Buy
6,331
+2,286
+57% +$75.3K ﹤0.01% 1438
2019
Q2
$128K Buy
+4,045
New +$120K ﹤0.01% 1545

Other funds holding PBH

Amundi Asset Management US's PBH Position: Q4 2020 in Review

Amundi Asset Management US sold out of Prestige Consumer Healthcare (PBH) in Q4 2020, closing a stake of 281 shares — an estimated $10K sold.

Amundi Asset Management US first reported a position in PBH in Q2 2019 and held it in 6 quarters. The position peaked at $256K in Q4 2019. 237 funds tracked by Wall St. Rank hold PBH as of Q4 2020.

  • Amundi Asset Management US reported no remaining Prestige Consumer Healthcare position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 281 Prestige Consumer Healthcare shares in Q4 2020, an estimated $10K.
  • Amundi Asset Management US first reported a position in Prestige Consumer Healthcare in Q2 2019 and held it in 6 quarters.
  • Amundi Asset Management US's Prestige Consumer Healthcare position peaked at $256K in Q4 2019.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.